BRCA in breast cancer: ESMO Clinical Recommendations

被引：37
作者：
Balmana, J. [1 ]
Diez, O. [2 ]
Castiglione, M. [3 ]
机构：
[1] Vall Hebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
[2] Vall Hebron Univ Hosp, Dept Genet, Barcelona, Spain
[3] Univ Geneva, Inst Social & Prevent Med, Geneva, Switzerland
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
MUTATION CARRIERS; FAMILIES; WOMEN; RISK;
D O I：
10.1093/annonc/mdp116
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：19 / 20
页数：2
相关论文
共 9 条
[1]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[2]   Clinical management of BRCA1 and BRCA2 mutation carriers [J].
Domchek, S. M. ;
Weber, B. L. .
ONCOGENE, 2006, 25 (43) :5825-5831
[3]   Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers:: a prospective cohort study [J].
Domchek, SM ;
Friebel, TM ;
Neuhausen, SL ;
Wagner, T ;
Evans, G ;
Isaacs, C ;
Garber, JE ;
Daly, M ;
Eeles, R ;
Matloff, E ;
Tomlinson, GE ;
Van't Veer, L ;
Lynch, HT ;
Olopade, O ;
Weber, BL ;
Rebbeck, TR .
LANCET ONCOLOGY, 2006, 7 (03) :223-229
[4]   Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations [J].
Fackenthal, James D. ;
Olopade, Olufunmilayo I. .
NATURE REVIEWS CANCER, 2007, 7 (12) :937-948
[5]   Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].
Ford, D ;
Easton, DF ;
Stratton, M ;
Narod, S ;
Goldgar, D ;
Devilee, P ;
Bishop, DT ;
Weber, B ;
Lenoir, G ;
Chang-Claude, J ;
Sobol, H ;
Teare, MD ;
Struewing, J ;
Arason, A ;
Scherneck, S ;
Peto, J ;
Rebbeck, TR ;
Tonin, P ;
Neuhausen, S ;
Barkardottir, R ;
Eyfjord, J ;
Lynch, H ;
Ponder, BAJ ;
Gayther, SA ;
Birch, JM ;
Lindblom, A ;
Stoppa-Lyonnet, D ;
Bignon, Y ;
Borg, A ;
Hamann, U ;
Haites, N ;
Scott, RJ ;
Maugard, CM ;
Vasen, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689
[6]   Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers:: an update [J].
Gronwald, J ;
Tung, N ;
Foulkes, WD ;
Offit, K ;
Gershoni, R ;
Daly, M ;
Kim-Sing, C ;
Olsson, H ;
Ainsworth, P ;
Eisen, A ;
Saal, H ;
Friedman, E ;
Olopade, O ;
Osborne, M ;
Weitzel, J ;
Lynch, H ;
Ghadirian, P ;
Lubinski, J ;
Sun, P ;
Narod, SA .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (09) :2281-2284
[7]   Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition [J].
Kriege, M ;
Brekelmans, CTM ;
Boetes, C ;
Besnard, PE ;
Zonderland, HM ;
Obdeijn, IM ;
Manoliu, RA ;
Kok, T ;
Peterse, H ;
Tilanus-Linthorst, MMA ;
Muller, SH ;
Meijer, S ;
Oosterwijk, JC ;
Beex, LVAM ;
Tollenaar, RAEM ;
de Koning, HJ ;
Rutgers, EJT ;
Klijn, JGM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) :427-437
[8]   Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. [J].
Meijers-Heijboer, H ;
van Geel, B ;
van Putten, WLJ ;
Henzen-Logmans, SC ;
Seynaeve, C ;
Menke-Pluymers, MBE ;
Bartels, CCM ;
Verhoog, LC ;
van den Ouweland, AMW ;
Niermeijer, MF ;
Brekelmans, CTM ;
Klijn, JGM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :159-164
[9]   Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer [J].
Walsh, T ;
Casadei, S ;
Coats, KH ;
Swisher, E ;
Stray, SM ;
Higgins, J ;
Roach, KC ;
Mandell, J ;
Lee, MK ;
Ciernikova, S ;
Foretova, L ;
Soucek, P ;
King, MC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (12) :1379-1388
1